Moelis & Co (MC) was Reiterated by UBS to “Neutral” according to the research note released today. The brokerage firm has raised the Price Target to $ 29 from a previous price target of $25 . UBS advised their investors in a research report released on Apr 28, 2016.
On the company’s financial health, Moelis & Co reported $0.35 EPS for the quarter, missing the analyst consensus estimate by $ -0.04 based on the information available during the earnings call on Apr 27, 2016. Analyst had a consensus of $0.39. The company had revenue of $126.36 million for the quarter, compared to analysts expectations of $139.89 million. The company’s revenue was up 27.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.28 EPS.
Moelis & Co opened for trading at $28.38 and hit $28.73 on the upside on Wednesday, eventually ending the session at $28.58, with a gain of 0.60% or 0.17 points. The heightened volatility saw the trading volume jump to 1,28,952 shares. Company has a market cap of $1,474 M.
Moelis & Company is an investment bank that provides strategic and financial advice to a client base including corporations Governments and financial sponsors. The Company assists its clients in achieving their strategic goals by offering financial advisory services across all industry sectors. It advices its clients on decisions including mergers and acquisitions (M&A) recapitalizations and restructurings and other corporate finance matters. With 17 offices located in North and South America Europe the Middle East Asia and Australia the Company provides information flow and cross-border capabilities. The Company offers advisory services in all industries including consumer retail and restaurants; financial institutions; financial sponsors; general industrials; healthcare; natural resources; real estate gaming lodging and leisure and technology media and telecommunications. It advises clients on all aspects of public and private debt and equity transactions.